The global market for human vaccines has experienced strong growth in the past few years, and R&D departments at many pharmaceutical companies are working on new prophylactics, some of which may see near-term marketing. What illnesses may see a vaccine option in the coming years? Which vaccines will have the most successful business model? Who are the major companies in this market, and possible new entrants? What can current vaccine success stories tell us about the future of the vaccine market? This Kalorama Information report What's Next in Vaccines? examines and estimates the market for vaccines that have yet to be launched, including the following target areas:
Some of these vaccines may see success; some could be the blockbusters of the future. For marketers and industry watchers a knowledge of all of the potential vaccines will be important to understand how pharma is seeking to renew bottom line with aggressive prophylactic strategies, and who the winners and losers in the near future may be. Alison Sahoo has looked at the vaccine market three times in as many years for Kalorama Information, and in this report applies a knowledge of what companies have done in the past to potential efforts. There are a number of trends that will impact the industry that market watchers will want to know about, and Kalorama Information has covered these trends; including: New Vaccine Technologies, DNA Vaccination, Innovative Delivery Systems, Edible Vaccines, Vaccine Patches, Funding Shortfalls. The report also discusses vaccine manufacturing methods and the approval process. In addition, the report focuses on the emerging vaccine activities of the following companies
Sales estimates for each market segment represent global revenues and are expressed in current dollars. Information for this report was gathered from a wide variety of published sources including company reports and filings, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Related Reports: Obesity, Weight Loss and Diet Management Markets (Pharmaceutical, Surgical and Dietary Approaches)Dec 1, 2009 - KLI1646597 - $3,500.00 Veterinary Diagnostics Markets Oct 1, 2009 - KLI2430295 - $995.00 The Market for Wellness Programs and Their Impact on Pharmaceutical, Diagnostic and Device Product Markets Oct 1, 2009 - KLI2384194 - $3,995.00 The Worldwide Market for Anti-Infectives (Antifungals, Antibacterials and Antivirals) Oct 1, 2009 - KLI2435380 - $3,500.00 Drug Delivery Markets: Implantable / Injectable and Needle-Free Delivery Systems Sep 1, 2009 - KLI2422083 - $2,995.00 Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry Jun 1, 2009 - KLI2155319 - $3,995.00 World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers) May 1, 2009 - KLI1829596 - $3,500.00 H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays) May 1, 2009 - KLI2241990 - $800.00 Retail Clinics and the In-Store Healthcare Market 2009: Bright Spot in the Current Economy? Mar 1, 2009 - KLI2041111 - $3,500.00 Stem Cell Therapeutics Markets Feb 1, 2009 - KLI2021959 - $2,500.00 |
800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Clinical Nutrition Products: World Markets, 3rd Edition
World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Vaccines 2009: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Lab Automation Markets Worldwide (Next-Generation Systems, Key Companies, Forecasts and Trends)
|
|||||||||
Email a colleague
Printer format
Order by fax|
Privacy Policy
|
Terms and Conditions
|
Site Map
|
Return Policy
|
Press
|
Help FAQs
|
